Abstract:Background: Chromosomal abnormality appeared during establishment or in vitro culture of some human embryonic stem cells. To establish human embryonic stem cell line with abnormal chromosome can analyze chromosome effects on human embryonic stem cells. Objective: To establish human embryonic stem cell line with abnormal chromosome. Design, time and setting: The cytology in vivo or vitro study was performed at the Reproductive Medicine Center, Gulou Hospital, Medical College, Nanjing University from October 2006 to February 2008. Materials: Frozen human embryo was supplied by Reproductive Medicine Center, Gulou Hospital, Medical College, Nanjing University. Fibroblasts from one 4-week NOD-soid mice and ICR fetal mice were provided by Animal Experimental Center, Gulou Hospital, Medical College, Nanjing University. Methods: Frozen human embryo was defrosted and incubated in the blastocyst medium. Inner cell mass was isolated from the blastocyst during the blastocyst extension stage. Fibroblasts from ICR fetal mice served as feeder layers. Cell passage was performed by the mechanical method. The human embryonic stem cell line was named as NJGLChES2. Main outcome measures: Cells from the!passage 10, 30, 50 were used for karyotype analysis. Human embryonic stem cells with abnormal karyotype were selected to identify the expression of alkaline phosphatase and specific marker. The cell differentiation was observed by in vitro embryoid formation and in vivo teratoma study. Results: NJGLChES2 human embryonic stem cell karyotype analysis results showed chromosome 16 (47, XX, +16), and showed clone-shaped growth of human embryonic stem cells. Cells were positive for OCT-4, SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81. In vitro cultured NJGLChES2 human embryonic stem cells formed cystic-shaped embryoid body. Teratoma formed at the subcutaneous inguina of NOD-scid mice in vivo. Tumor tissue contained various cells from the tabular epithelium, striated muscle and respiratory tract mucosa epithelium. Conclusion: We established a new human embryonic stem cell line NJGLChES2 with trisomy 16. The line is undifferentiated and has the capacities of multi-directional differentiation.

Establishment of a human embryonic stem cell line with trisomy 16